Solvonis Therapeutics plc (LON:SVNS)
London
· Delayed Price · Currency is GBP · Price in GBX 0.1650
+0.0200 (13.79%)
At close: May 9, 2025, 4:30 PM BST
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 3.79 million as of May 9, 2025. Its market cap has increased by 2,499.42% in one year.
Market Cap
3.79M
Enterprise Value
3.03M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
Market Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 3.79M, a decrease of -83.55%. That is a compound annual growth rate of -41.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 3.79M | -19.51% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 157.14B |
| HSBC Holdings | 147.87B |
| Shell | 145.57B |
| Unilever | 117.30B |
| Rio Tinto Group | 76.50B |
| RELX PLC | 74.01B |
| British American Tobacco p.l.c. | 71.02B |
| Rolls-Royce Holdings | 66.43B |